Candesartan Dibromo N2-Trityl Impurity

Product Description
CAT No.
ALN-C011020
CAS No.
151052-34-5
Mol. F.
C33H24Br2N4
Mol. Wt.
636.4
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 5-(4′-(Dibromomethyl)(1,1′-biphenyl)-2-yl)-2-trityl-2H-tetrazole ;
Smiles : BrC(Br)C(C=C1)=CC=C1C2=CC=CC=C2C3=NN(C(C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)N=N3
Inchi : InChI=1S/C22H16N6O3/c29-21(30)17-6-3-7-18-19(17)28(22(31)23-18)12-13-8-10-14(11-9-13)15-4-1-2-5-16(15)20-24-26-27-25-20/h1-11H,12H2,(H,23,31)(H,29,30)(H,24,25,26,27)
Synonym : Irbesartan Dibromo N2-Trityl Impurity ; Losartan Dibromo N2-Trityl Impurity ; Olmesartan Dibromo N2-Trityl Impurity ; Valsartan Dibromo N2-Trityl Impurity ; Candesartan Dibromo TTBB Impurity ;
Technical Data
Reference
Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR
Bhanu Ramana,u2217, Brajesh A. Sharmaa,b, Ganesh Mahale b, Dharmendra Singhb, Ashok KumarnJournal of Pharmaceutical and Biomedical Analysis 56 (2011) 256u2013263
Synergistic suppression of tumor angiogenesis by codelivering of VEGF targeted siRNA and candesartan mediated by functionalized carbon nanovectors
Xuefang Ding, Yujie Su, Cheng Wang, Fangrong Zhang, Kerong Chen, Yu Wang, Min Li, and Wei Wang – ACS Appl. Mater. Interfaces 2017, 9, 28, 23353–23369
Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil Tablets
Arivozhi Mohan1,&, S. Shanmugavel1 , Ajay Goyal1 , B. R. Venkataraman2 , D. Saravanan – Chromatographia volume 69, pages1211–1220(2009)
RFQ